IntegriChain| Investments | Nordic Capital
Integrichain Header A 72Ppi

IntegriChain

Platform for pharma commercialisation and market access

IntegriChain is a fully-integrated platform for pharma commercialisation and market access. By providing pharmaceutical technology, data, consulting, and outsourcing solutions, IntegriChain improves how medicines reach customers and helps manufacturers bring their science to market.

Company Background

  • As a leading biopharma commercialisation technology, data and insights platform, IntegriChain helps pharma manufacturers of all sizes bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapies.

  • The Company delivers Pharma's only data-driven commercialisation platform, from strategy to operational execution, and has a unique focus on data, technology, consulting, and outsourcing which connects the commercial, financial, and operational dimensions of drug access and profitability.

  • IntegriChain supports more than 400 pharmaceutical customers. Its ICyte Platform enables pharmaceutical innovators to achieve better commercial outcomes by digitalising daily and recurring business activities and by integrating data and operations across contracting, pricing, channel & distribution, and gross-to-net.

Vision & Outlook

  • IntegriChain is well positioned to help accelerate an industry-wide transformation by providing greater market access transparency and forecasting capabilities, ultimately enabling pharmaceutical innovators to achieve better commercial outcomes.

  • The partnership with Nordic Capital will seek to accelerate IntegriChain’s ambitious growth targets and extend its position as a leading platform for pharma manufacturers to bring their science to market.

  • Through its experience in supporting HealthTech companies with similar growth ambitions, deep-sector knowledge and extensive industry network, Nordic Capital aims to help realise IntegriChain’s full potential.
Integrichain Logo Vertical

SECTOR

Healthcare

Technology & Payments

REVENUES 2023

EUR 110 million

EMPLOYEES

700

OWNERSHIP

Nordic Capital XI

INVESTMENT DATE

2023

HEAD OFFICE

Philadelphia, PA, USA

MANAGEMENT

Josh Halpern

CEO

Darren Weiss

CFO

CHAIRPERSON

Jim Meyers

RESPONSIBLE ADVISOR

Daniel Berglund

Partner | Co-Head of Healthcare | Head of U.S.

Nordic Capital's Technology & Payments focus

Having invested in the sector for more than two decades, Nordic Capital is one of the most experienced Technology & Payments investors in Northern Europe. Focus is set on companies with great potential to drive superior growth and benefit from fundamental market trends.

Learn more here:

Nordic Capital's healthcare focus

Nordic Capital is one of the most active and experienced investors in healthcare globally, focusing on investments in companies throughout the healthcare space with potential to grow and expand into new markets and industry-leading innovations or value propositions.

Learn more here: